(GVIP) Goldman Sachs Hedge - Overview

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US3814305450

Etf: Technology, Healthcare, Consumer, Financial, Industrial

Total Rating 44
Risk 52
Buy Signal 0.42

Dividends

Dividend Yield 0.33%
Yield on Cost 5y 0.54%
Yield CAGR 5y 261.35%
Payout Consistency 60.0%
Payout Ratio -
Risk 5d forecast
Volatility 26.9%
Relative Tail Risk 3.42%
Reward TTM
Sharpe Ratio 0.67
Alpha 2.48
Character TTM
Beta 1.133
Beta Downside 1.169
Drawdowns 3y
Max DD 23.29%
CAGR/Max DD 1.18

Description: GVIP Goldman Sachs Hedge December 29, 2025

The Goldman Sachs Hedge Industry VIP ETF (NYSE ARCA: GVIP) aims to track an index that selects large-cap growth equities whose price movements are believed to have a material impact on the aggregate long-only portfolios of hedge funds. To meet its mandate, the fund invests at least 80 % of its net assets in the underlying index constituents, including both domestic shares and foreign-issued depositary receipts that represent those shares.

As of the most recent filing (Q3 2024), GVIP carries an expense ratio of 0.45 % and manages roughly $310 million in assets, with the top ten holdings-dominated by Apple, Microsoft, Amazon, Alphabet, and Nvidia-accounting for about 45 % of the portfolio. The ETF’s performance is closely tied to macro-level drivers such as hedge-fund equity allocation trends, U.S. monetary-policy stance, and the health of the technology sector, which together explain a significant portion of its beta to the broader market.

For a deeper, data-driven view of how GVIP’s factor exposures compare to peers, you might find ValueRay’s analytics platform useful as a next step in your research.

What is the price of GVIP shares?

As of February 08, 2026, the stock is trading at USD 156.57 with a total of 25,566 shares traded.
Over the past week, the price has changed by -1.46%, over one month by -2.19%, over three months by +3.45% and over the past year by +18.72%.

Is GVIP a buy, sell or hold?

Goldman Sachs Hedge has no consensus analysts rating.

What are the forecasts/targets for the GVIP price?

Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 187.2 19.6%

GVIP Fundamental Data Overview February 04, 2026

Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 464.2m USD (464.2m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 464.2m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 464.2m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 10.09% (E(464.2m)/V(464.2m) * Re(10.09%) + (debt-free company))
Discount Rate = 10.09% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)

Additional Sources for GVIP ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Fund Manager Positions: Dataroma | Stockcircle